Clinical Trial Update: Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating anastrozole in postmenopausal women with ductal carcinoma in situ or Stage I-III breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Drugs mentioned

• ARIMIDEX (anastrozole)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED